Your browser doesn't support javascript.
loading
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.
Galleu, Antonio; Riffo-Vasquez, Yanira; Trento, Cristina; Lomas, Cara; Dolcetti, Luigi; Cheung, Tik Shing; von Bonin, Malte; Barbieri, Laura; Halai, Krishma; Ward, Sophie; Weng, Ling; Chakraverty, Ronjon; Lombardi, Giovanna; Watt, Fiona M; Orchard, Kim; Marks, David I; Apperley, Jane; Bornhauser, Martin; Walczak, Henning; Bennett, Clare; Dazzi, Francesco.
Afiliación
  • Galleu A; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • Riffo-Vasquez Y; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.
  • Trento C; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • Lomas C; Institute of Immunity and Transplantation, University College London, London NW3 2QG, UK.
  • Dolcetti L; Cancer Institute, University College London, London WC1E 6DD, UK.
  • Cheung TS; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • von Bonin M; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • Barbieri L; University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
  • Halai K; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • Ward S; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • Weng L; Institute of Immunity and Transplantation, University College London, London NW3 2QG, UK.
  • Chakraverty R; Cancer Institute, University College London, London WC1E 6DD, UK.
  • Lombardi G; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
  • Watt FM; Institute of Immunity and Transplantation, University College London, London NW3 2QG, UK.
  • Orchard K; Cancer Institute, University College London, London WC1E 6DD, UK.
  • Marks DI; Medical Research Council Centre for Transplantation, King's College London, London SE1 9RT, UK.
  • Apperley J; Centre for Stem Cells and Regenerative Medicine, King's College London, London SE1 9RT, UK.
  • Bornhauser M; University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.
  • Walczak H; Bristol Haematology and Oncology Centre, Bristol BS2 8ED, UK.
  • Bennett C; Centre for Haematology, Imperial College London, London W12 0NN, UK.
  • Dazzi F; Regenerative Medicine, Division of Cancer Studies and Cancer Research UK King's Health Partners, King's College London, London SE5 9NU, UK.
Sci Transl Med ; 9(416)2017 Nov 15.
Article en En | MEDLINE | ID: mdl-29141887

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Apoptosis / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Apoptosis / Células Madre Mesenquimatosas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido